Immunomodulatory Effects of Lucilia sericata in Wound Healing: A Summary of Current Evidence


Creative Commons License

Polat N.

X. INTERNATİONAL SCİENCE AND ACADEMİC CONGRESS (INSAC-2025). International Research Congress on Health and Life Sciences (INSAC-IRHES 2025), Çanakkale, Türkiye, 9 - 11 Ekim 2025, ss.6-7, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Çanakkale
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.6-7
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet

Özet

The use of Lucilia sericata larvae, commonly referred to as medicinal maggots, has garnered

increasing attention in wound care due to their multifaceted therapeutic properties. Beyond their wellestablished

debridement capabilities, recent studies have highlighted their immunomodulatory effects,

which play a crucial role in enhancing wound healing. These larvae secrete a complex mixture of bioactive

compounds, including proteolytic enzymes, antimicrobial peptides, and growth-promoting factors that

influence the local immune response. One of the key mechanisms involves modulating inflammatory

cytokines. Research indicates that larval secretions can downregulate pro-inflammatory mediators such as

tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), while upregulating anti-inflammatory

cytokines like interleukin-10 (IL-10), thereby promoting a balanced immune environment conducive to

tissue regeneration. Additionally, L. sericata excretions have been shown to stimulate fibroblast

proliferation and angiogenesis, both essential for granulation tissue formation and epithelialization.

Moreover, the antimicrobial properties of larval secretions contribute to reduced bacterial load in chronic

wounds, indirectly supporting immune function by alleviating persistent infection—a major barrier to

healing. Studies also suggest that these secretions can inhibit biofilm formation by pathogenic bacteria

such as Staphylococcus aureus and Pseudomonas aeruginosa, further enhancing the wound

microenvironment. Importantly, the immunomodulatory effects of L. sericata are not limited to local wound

sites. Emerging evidence points to systemic immune benefits, including improved leukocyte function and

enhanced oxidative stress response, although these findings require further validation through clinical

trials. In conclusion, Lucilia sericata larvae offer a promising biotherapeutic approach in wound

management, not only through mechanical debridement but also via immunological modulation. Their

ability to regulate inflammatory pathways, promote tissue regeneration, and combat infection positions

them as a valuable tool in treating chronic and non-healing wounds. Future research should aim to isolate

and characterize the specific bioactive molecules responsible for these effects, paving the way for novel

pharmacological applications in regenerative medicine.